Illinois 2025 2025-2026 Regular Session

Illinois Senate Bill SR0241 Introduced / Bill

Filed 04/25/2025

                    <tr><td class="xsl" colspan="3"><p> </p> </td></tr></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SR0241</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 13255 MST 25450 r</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><center><code>SENATE RESOLUTION</code></center> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, Amyotrophic lateral sclerosis (ALS), known by </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>many as Lou Gehrig's disease, is a progressive fatal </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>neurodegenerative disease in which a person's brain loses </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>connection with the muscles, slowly taking away their ability </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>to walk, talk, eat, and eventually breathe; and</code> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, ALS has no cure, and every 90 minutes, someone is </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>diagnosed with ALS and someone passes away from ALS; on </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>average, patients diagnosed with ALS only survive two to five </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>years from the time of diagnosis; and</code> </td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, People who have served in the military are more </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>likely to develop ALS and die from the disease than those with </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>no history of military service; and</code> </td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, Securing access to new therapies, durable medical </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>equipment, and communication technologies is of vital </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>importance to people living with ALS; and</code> </td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, Clinical trials play a pivotal role in evaluating </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>new treatments, enhancing quality of life, and fostering </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>assistive technologies for those living with ALS; and</code> </td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, This year marks the 11th anniversary of the Ice </code></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SR0241</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 13255 MST 25450 r</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>Bucket Challenge, and it is fitting to make a renewed </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>commitment to galvanize public awareness and support funding </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>leading to significant investments in ALS research; and</code> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, The ALS Association, as the largest philanthropic </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>funder of ALS research globally, has committed over $154 </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>million to support more than 550 projects across the United </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>States and 18 other countries; and</code> </td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, The ALS community and researchers remain </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>unwaveringly committed to accelerating the pace of discovery, </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>fueled by the hope that one day ALS will be a livable disease </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>for everyone, everywhere; and</code> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>WHEREAS, Observing ALS Awareness Month increases the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>public's awareness of the dire circumstances faced by people </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>living with ALS, acknowledges the terrible impact this disease </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>has, not only on the person but on his or her family and the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>community, and recognizes the research being done to eradicate </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>this disease; therefore, be it</code> </td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>RESOLVED, BY THE SENATE OF THE ONE HUNDRED FOURTH GENERAL </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>ASSEMBLY OF THE STATE OF ILLINOIS, that we declare May 2025 as </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>ALS Awareness Month and urge all Americans to join in </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>supporting ALS research, advocating for increased funding, and </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>standing in solidarity with those affected by this relentless </code></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SR0241</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 13255 MST 25450 r</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>disease.</code>